Oxford Brookes Professor awarded grant to fund research that could reduce recurrence of breast cancer

Thursday, 12 September 2019

Eila Watson

Oxford Brookes Professor awarded grant to Fund research that could reduce recurrence of breast cancer

Professor Eila Watson (Faculty of Health and Life Sciences) has won an award from the National Institute of Health Research and will be working with a large group of multi-disciplinary researchers, Co leading a project exploring adherence to hormone therapy for breast cancer, with Prof Linda Sharp from University of Newcastle, who is leading.

Most women with breast cancer are prescribed hormone therapy in the form of a daily tablet for 5-10 years following initial treatment. This is because there is strong evidence that hormone therapy significantly reduces the risk of breast cancer recurring. However, there is good evidence that adherence to hormone therapy is poor, with around 20% of women having 'poor' adherence at two years and around 50% at five years.
Eila said;
 

''Our previous research has explored the reasons for this poor adherence, and this programme grant will work with women and health professionals to develop and trial a support package designed to help women continue taking this medication, thereby reducing recurrence of breast cancer"

Further information about Eila and her research, is here